Gough M, Kwah KKX, Khan T, Ghosh S, et al. Receptor CDCP1 Is a Potential Target for Personalized Imaging and Treatment of Poor Outcome HER2+, Triple-Negative, and Metastatic ER+/HER2- Breast Cancers. Clin Cancer Res 2025;31:1504-1519.
PMID: 39869307